Documente Academic
Documente Profesional
Documente Cultură
INCROPORATED
EXECUTIVE SUMMARY
U.S. SPENDS 180 BILLION
DOLLARS A YEAR ON ANTIAGING/ IT WILL DOUBLE BY
2018-MAYO CLINIC
COR MEDICA TECHNOLOGY provides both the strategic
expertise of traditional management and technical planning capability based on proven
scientific research in STEM CELLS, Cutting Edge Diagnostics and Therapy. This is the expansion
of a currently successful MEDICAL ORGANIZATION created by Doctor Fouad Ghaly of West Los
Angeles, California.
Executive Summary
Page 1
Opportunity:
MEET PATIENTS UNDERSEVED, UNSERVED AND UNKOWN DEMAND FOR
CUTTING EDGE REGENITIVE MEDECINE, DIONOSTICS AND THEARPY. SUPPLYING
CLIENTS WITH THE LATEST AND GREATEST MEDICAL CARE IN THE WORLD.
USING THE LATEST STEM CELL RESEARCH AND PATENDED COR MEDICA ECP
MACHINE.
PAUL ORLOFF, ESQUIRE, PRESIDENT AND CEO
DR. FOUAD GHALY, M.D. MEDICAL DIRECTOR, PROFESSOR JOHN HOPKINS
UNIVERSITY
CHAUNCEY SAYRE, PHD., CSO, STEM CELL RESEARCH SCIENTIST
DR. ROBERT MORIN, MD, PHD, CHAIRMAN UCLA MEDICAL SCHOOL
DR. FARCAN RAJPUT, MD CARDIOLOGIST, HOAG HOSPITAL
KATALIN COSKA, MD, PHD, VICE PRESIDENT STEM CELL RESEARCH
JAN MIKESELL, PHD, OHIO STATE UNIVERSITY
ROBERT PRESTWOOD, VICE PRESIDENT MARKETING
COLLEEN MURPHY, RN, HOAG HOSPITAL EXECUTIVE, MEDICAL ADVISOR
LISA MARIE MIKESELL, PHD, UCLA ADVISOR
BRITTA WETTESKIND, RN
The Concept:
Page 2
PREVENT HEALTH ISSUES BEFORE YOU HAVE THE SIMPTONS. NOT ONLY TREAT
SYMPTONS OF ACUTE PROBLEMS.
OUT THEARPY IS ALWAYS PROVEN BY SCIENTIFIC RESEARCH AND MANY TIMES
IS FAR MORE COST EFFECTIVE THAN THE TRIDITIONAL PROGRAMS OF
TREATMENT WHERE YOU ARE ONLY ADRESSING SIMPTOMS TO ACCUTE ISSUES.
EXAMPLE: USE COR MEDICA ECP THEARPY AS PART OF YOUR HEALTH
MAINTAINENCE PROGRAM TO PREVENT OR REDUCE THE EFFECTS CARDIO
VASCULAR ISSUES.
Use existing Strategic referral partnerships. Recognizing the WORLD market needs, our unique
approach is to provide THE LATEST AND GREATEST MEDICAL CARE EVER. We will expand our
synergistic global community of business partners and consumers created by our Medical
Director, Dr. Fouad Ghaly, MD.
Market the wide range of products and services currently used in Dr. Ghalys highly successful
West Los Angeles Medical Practice where his medical advice is sought by billionares and movie
stars the world over. Most of these individuals may not be named. Kirk Douglas, Jean Simons,
Shirley McLean, Michael Douglas, Sting and Rod Stuart are a few who may.
Milestones
THE COR MEDICA ECP MACHINE, tm
THE COR MEDICA TECHNOLOGY PRP INJECTION ( stem cell treatment )
Strategic Advantages:
Page 3
COR MEDICA TECHNOLOGY is in on the cutting edge of stem cell research using your
own DNA
Proprietary Technology- COR MEDICA CREATED BEST WORLDS BEST ECP MACHINE
Service Marks and Domain Names- THE NATURAL COR MEDICA BYPASS tm sm,
CMTECP tm
Strategic Partnerships- CARDIOLOGISTS, PRIMARY CARE DOCTORS, UNIVERSITIES,
HOSPITALS, BIOTECH COMPANIES, STEM CELL RESEARCH SCIENTISTS and BIOTECH
ENGINEERS
BEST RESEARCH, INVENTIONS, INNOVATIONS AND EXISTING SUCCESSFUL BEST
PRACTICES BUSINESS MODEL
Sources of Revenue:
COR MEDICA ECP TREATMENTS COR MEDICA TECHNOLOGY CLINICS WILL
SERVICE MEDICARE PATIENTS AND MOST ALL OTHER MEDICAL INSURANCE
PROVIDERS
PRP STEM CELL TREATMENTS ARE BEGINNING TO BE COVERED BY MANY
MEDICAL INSURANCE COMPANIES
LEASING OF THE COR MEDICA ECP MACHINES TO HOSPITALS, DOCTORS, CLINICS
AND OTHER MEDICAL INSTUTIONS WITH NO UP FRONT COSTS
PRODUCTS: COR MEDICA ECP MACHINE, INTERNATIONAL SALES AND SERVICE
MEDICAL CARE INCLUDING STEM CELL INJECTIONS
A PIPELIME OF INVENTIONS AND RESEARCH CURRENTLY IN THE DEVELOPMENT
STAGE
FINANCING OF MEDICAL EQUIPMENT TO HOSPITALS, DOCTORS AND CLINICS
WITH NO UP FRONT COSTS WILL CONTINUE DEEP MARKET PENETRATION
WORLD WIDE
ACQUISITION OF MEDECIAL BUILDINGS WORLDWIDE, MEDICAL BUILDING
BEING THE MOST STABLE ROI OF COMMERCIAL REAL ESTATE REVENUE
Page 4
Services Description
What is ECP?
External Counter Pulsation (ECP) is a nonsurgical therapy for: stroke, angina, heart disease,
high blood pressure, erectile dysfunction and other conditions involving poor circulation.
Page 5
By encouraging the formation of collaterals around blockages in the coronary arties, ECP
enhances the hearts supply of oxygen and reduces chest pain. Several studies conducted at
leading university medical centers have shown that patients who undergo a course of ECP
experiences significant benefits.
Unlike drugs that are prescribed for angina, COR MEDICA ECP is completely safe and effective.
And unlike angioplasty and bypass surgery highly invasive surgical interventions that are used
to clear or circumvent blockages in the arteries ECP can be done on an outpatient basis and
requires no post treatment recovery period. ECPs benefits in heart disease are now well
recognized that Medicare reimburses for it.
Many patients undergo COR MEDICA ECP after suffering a heart attack or enduring one or even
several surgeries for coronary heart disease.
In some cases, ECP is the only option.
Page 6
For a growing number of patients, opting for ECP before consenting to a potentially dangerous
surgical procedure is an obvious decision.
In less time to recovery from surgery, patients can complete a full course of ECP and begin
enjoying an active, pain-free life.
Physicians, patients, and family members
are welcome to contact COR MEDICA TECHNOLOGY for more
information: EMAIL CORMEDICATECH@GMAIL.COM
Market Overview
According to the U.S. Surgeon General, coronary heart disease (CHD) is the number one cause
of death in the United States. Total spending on treatments for heart disease in the United
States is currently more than $117 billion per year. A major complication of CHD is Chronic
Heart Angina Pectoris, which millions of Americans suffer.
About 220,000 per year die from CHD without being hospitalized.
In order to minimize these drastic numbers, it is essential to provide proper screening,
educating, and treating as well as improve populations overall health and quality of life. We do
so by implementing our treatment technology and programs in the communities. The
introduction of Cor Medica Counter Pulsation Therapy (CMCPT) to all communities will allow us
to position ourselves in the community as an innovator of safe, effective and easy to use cardio
vascular therapy worldwide. The ECP treatment technology is now FDA approved.
About $10.8 billion was paid to Medicare beneficiaries for CHD in 1997. This number is
estimated to grow 50 billion by 2015.
Aside of being an alternative to a complicated and dangerous heart surgery, the COR MEDICA
ECP TREATMENT is very cost effective while the risks associated with the treatment are NONE.
Page 7
Marketing efforts will be directed toward executing the company strategy of building a network
of complementary strategic partnerships that will drive use of our services and products. The
company will develop strong alliances with key organizations to help bring credibility AND
DRIVE SALES OF OUR SERVICES AND PRODUCTS.
MARKETING TO OUR REFERAL PARTNERS: doctors, hospitals and universities.
CARDIOLOGISTS
HEALTH FAIRS
TRADE SHOWS
DIRECT CONSUMER SALES
SOCIAL MEDIA
MASS MEDIA
PUBLIC RELATIONS
DIRECT MAIL
INTERNET MARKETING
Financial Overview
A complete set of financials is found in Business Plan but key metrics include:
(See excel attachment Exhibit 1)
SOME KEY POINTS TO CONSIDER FOR COR MEDICA ECP
MEDICARE PAYS APPROXIMATELY $230 PER TREATMENT (35 IN EACH SERIES)ABOUT $8,000
TOTAL
KAISER PERMENTE PAYS APPROXIMATELY $255 PER TREATMENT (35 IN SERIES)
WALK-IN CASH ATHLETIC TREATMENTS $95 for COR MEDICA ECP 1HR
WE NOW HAVE THE ABILITY TO BILL ALL MAJOR PPOS, MEDICARE AND KAISER PERMENTE.
WE ALSO WILL BE ABLE TO UTILIZE DR. GHALYS CONTRACT WITH KAISER PERMENTE
NATIONALY.
Page 8
COR MEDICA ECP / ERECTILE DISFUNCTION AND NITRIC OXIDE THE GREAT GAS
Inside your body, you have a short-lived gas that tremendously affects many body functions.
This miracle gas-NITRIC OXIDE- has a short life. COR MEDICA ECP THEARPY greatly increases
your nitric oxide levels.
LOW LEVELS OF NITRIC OXIDE IS THE KEY CAUSE OF ERECTILE DYSFUNCTION AND OTHER AGE
RELATED AND ARTERY RELATED PROBLEMS. NITRIC OXIDE turns on a chain reaction in our cells
that allows our blood vessels to relax and dilate. People with atherosclerosis commonly do not
make enough NITRIC OXIDE to keep their arteries open. The common angina treatment
nitroglycerine increases NITRIC OXIDE, dilating blood vessels and thus decreasing heart pain.
THE COR MEDICA NITRIC OXIDE ENHACEMENT IS OUR UNIQUE METHOD TO INCREASE THE
PATIENTS NITRIC OXIDE LEVEL TO THE VERY HIGHEST LEVEL POSSIBLE DURING COR MEDICA ECP
THEARPY.
CORMEDICATECH@GMAIL.COM
Page 9